|会社名||DENTSPLY International Inc. （デンツプライ・インタ―ナショナル）|
|分野（sector）||Health Care ヘルスケア|
|業種||医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care）|
|概要||事業概要 デンツプライ・シロナ（DENTSPLY SIRONA Inc.）はプロ歯科用製品の製造及び技術提供に従事する企業である。同社は歯科および口腔衛生製品、並びにその他の消耗品医療機器を含むソリューション・オファリングを開発・製造・販売する。同社は歯科医療用消耗品及び技術の2つの事業区分を運営する。歯科産業は、歯、歯茎および支持骨の疾患と病気の診断・治療・予防に関与する。主な歯科製品カテゴリーは、歯科用消耗品、歯科用ラボ用製品、歯科用特殊製品、及び歯科用機器である。消耗品の医療機器製品は、泌尿器科および外科手術の用途に使用される。これらの製品は、米国及び国際的に会社によって生産され、「ANKYLOS」、「AQUASIL ULTRA」、「ARTICADENT」、「ATLANTIS」、「CALIBRA」、「CAULK」、「CAVITRON」、「CELTRA」、「DELTON」、「DENTSPLY」、「DETREY」および「DYRACT」を含む複数のブランド名で世界中に販売される。 デンツプライ・インタ―ナショナルは米国の歯科用製品メ―カ―。主要な製品には、麻酔薬、虫歯予防シ―ラント、印象材などの歯科用消耗品ほか、人工歯、貴金属合金、歯冠材などの歯科技工製品、また、歯根管治療器具・材料、インプラント、歯科矯正器具などの特殊治療製品を含む。同社製品は世界120カ国以上で販売される。 Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with a 134-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona's products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry.|
|本社所在地||221 West Philadelphia Street York PA 17405-2558 USA|
|代表者氏名||Donald M. Casey ドナルド・M・ケイシー|
|代表者役職名||Chief Executive Officer Director 最高経営責任者（CEO）|
|市場名||NASDAQ National Market System|
|決算概要||決算概要 BRIEF: For the six months ended 30 June 2018 DENTSPLY SIRONA Inc revenues increased 6% to $2B. Net loss before extraordinary items increased 5% to $1.04B. Revenues reflect Europe segment increase from $29.5M to $852.2M United States segment increase from $18.1M to $630.2M. Higher net loss reflects Restructuring and other costs increase from $84.8M to $199.1M (expense) Selling.|
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Dentsply Sirona, Inc. - XRAY 2022/06/09 02:50:00 GlobeNewswire
CEDARHURST, N.Y., June 08, 2022 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Dentsply Sirona, Inc. (NasdaqGS: XRAY), if they purchased the Company’s shares between June 9, 2021 and May 9, 2022, inclusive (the “Class Period”). Shareholders have until August 1, 2022 to file lead plaintiff applications in the securities class action lawsuit.
XRAY INVESTOR NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – XRAY 2022/06/08 19:50:00 GlobeNewswire
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than August 1, 2022 .
Bronstein, Gewirtz & Grossman, LLC Notifies Dentsply Sirona, Inc. (XRAY) Investors of Class Action and Encourages Investors to Contact the Firm 2022/06/08 15:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Dentsply securities between June 9, 2021 and May 9, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: ww
DENTSPLY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dentsply Sirona, Inc. - XRAY 2022/06/08 03:33:00 GlobeNewswire
NEW ORLEANS, June 07, 2022 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 1, 2022 to file lead plaintiff applications in a securities class action lawsuit against Dentsply Sirona, Inc. (NasdaqGS: XRAY), if they purchased the Company’s shares between June 9, 2021 and May 9, 2022, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of Ohio.
XRAY INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages DENTSPLY SIRONA Inc. (XRAY) Investors with Over $1 Million Losses to Contact Firm''s Attorneys, Securities Fraud Case Filed 2022/06/07 16:01:00 PR Newswire
SAN FRANCISCO , June 7, 2022 /PRNewswire/ -- Hagens Berman urges DENTSPLY SIRONA Inc. (NASDAQ: XRAY) investors who have suffered over $1 million losses to submit your losses now. A securities fraud class action has been filed and certain investors have an opportunity to lead the case….
Insights on the Dental Cement Global Market to 2026 - Featuring 3M, Cosmedent and Ivoclar Vivadent Among Others - ResearchAndMarkets.com 2022/01/10 10:55:00 Kwhen Finance
Dental Hand Instruments Market is Projected to Expand at a Steady CAGR over the Forecast by 2027 Covid-19 Analysis | 3M (US), Dentsply Sirona (US) 2021/12/23 14:16:30 OpenPR
This Dental Hand Instruments market report categorizes the market by applications, end user, product type, and geographies, which include Latin America, Africa, North America, Asia Pacific, Europe, and the Middle East. It assists in making the appropriate investment decisions
Ninety One North America Inc. Increases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) 2021/12/22 16:40:45 Transcript Daily
Ninety One North America Inc. lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 25.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 161,628 shares of the medical instruments suppliers stock after acquiring an additional 32,349 shares during the quarter. 
AMG National Trust Bank Sells 3,138 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) 2021/12/18 13:34:42 Transcript Daily
AMG National Trust Bank decreased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 10.2% during the third quarter, HoldingsChannel reports. The fund owned 27,719 shares of the medical instruments suppliers stock after selling 3,138 shares during the quarter. AMG National Trust Banks holdings in DENTSPLY SIRONA were worth $1,609,000 as of its most 
Dentsply Sirona Returns To Profit In Q2 Beating The Street On Revenue Surge; Backs Full-year View 2021/08/05 12:04:40 Business Insider Markets
(RTTNews) - Dentsply Sirona (XRAY) on Thursday reported net income of $99 million or $0.45 per share in the second quarter compared with net loss of $95 million or $0.44 per share in the comparable quarter a year ago, on more than 100% sales growth. Excluding items, earnings were $0.71 per share, that beat the average estimate of 14 analysts
Dentsply Sirona Reports Second Quarter 2021 Results 2021/08/05 10:00:00 Intrado Digital Media
CHARLOTTE, N.C., Aug. 05, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (Dentsply Sirona or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2021.
Global Cosmetic Dentistry Market Estimated-Henry Schein, Danaher Corporation, DENTSPLY Sirona, Envista Holdings, Align Technology 2021/07/29 17:09:02 OpenPR
The proposed Cosmetic Dentistry Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed
Subperiosteal Dental Implants Market 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Analysis, Forecast Report 2021/07/26 11:03:00 Intrado Digital Media
Some of the leading players operating in the global subperiosteal dental implants market are Institut Straumann AG, Dentsply Sirona Inc., Nobel Biocare Services AG, Zimmer Biomet, and Bio3 Implants GmbH. Some of the leading players operating in the global subperiosteal dental implants market are Institut Straumann AG, Dentsply Sirona Inc., Nobel Biocare Services AG, Zimmer Biomet, and Bio3 Implants GmbH.